Correlation Between Virios Therapeutics and Hillstream Biopharma

Can any of the company-specific risk be diversified away by investing in both Virios Therapeutics and Hillstream Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virios Therapeutics and Hillstream Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Virios Therapeutics Llc and Hillstream Biopharma, you can compare the effects of market volatilities on Virios Therapeutics and Hillstream Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virios Therapeutics with a short position of Hillstream Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virios Therapeutics and Hillstream Biopharma.

Diversification Opportunities for Virios Therapeutics and Hillstream Biopharma

0.61

Correlation Coefficient

Virios Therapeutics  Hillstream Biopharma

Poor diversification

The 3 months correlation between Virios and Hillstream is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Virios Therapeutics Llc and Hillstream Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hillstream Biopharma and Virios Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virios Therapeutics Llc are associated (or correlated) with Hillstream Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hillstream Biopharma has no effect on the direction of Virios Therapeutics i.e., Virios Therapeutics and Hillstream Biopharma go up and down completely randomly.

Pair Corralation between Virios Therapeutics and Hillstream Biopharma

If you would invest  458.00  in Virios Therapeutics Llc on September 3, 2024 and sell it today you would lose (63.00) from holding Virios Therapeutics Llc or give up 13.76% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	2.78%
Values	Daily Returns

Virios Therapeutics Llc  vs.  Hillstream Biopharma

Virios Therapeutics Llc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Virios Therapeutics Llc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly uncertain basic indicators, Virios Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Hillstream Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hillstream Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Hillstream Biopharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Virios Therapeutics and Hillstream Biopharma

The main advantage of trading using opposite Virios Therapeutics and Hillstream Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virios Therapeutics position performs unexpectedly, Hillstream Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hillstream Biopharma will offset losses from the drop in Hillstream Biopharma's long position.

The idea behind Virios Therapeutics Llc and Hillstream Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.